72.21
前日終値:
$73.85
開ける:
$73.53
24時間の取引高:
15.54M
Relative Volume:
1.14
時価総額:
$107.15B
収益:
$20.08B
当期純損益:
$2.89B
株価収益率:
37.24
EPS:
1.9391
ネットキャッシュフロー:
$3.66B
1週間 パフォーマンス:
-1.73%
1か月 パフォーマンス:
-4.36%
6か月 パフォーマンス:
-32.70%
1年 パフォーマンス:
-30.31%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific : 3 ways we're reducing the environmental impact of our devices - marketscreener.com
TD Cowen reiterates Boston Scientific stock rating on guidance confidence - Investing.com
Boston Scientific stock hits 52-week low at 72.63 USD - Investing.com
Boston Scientific Corporation Investigated by the Portnoy Law Firm - GlobeNewswire Inc.
Boston Scientific: Near-Term EP Reset but 2027 Growth Drivers Support Buy Rating - TipRanks
Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future - simplywall.st
Boston Scientific (BSX) SVP converts RSUs, withholds 372 shares for taxes - Stock Titan
Boston Scientific (NYSE: BSX) Explains Rationale for Penumbra Deal - Stock Titan
Boston Scientific Corp Stock Moved Down by 3.32% on Mar 3: Facts Behind the Movement - TradingKey
Boston Scientific Corp.: Why This Quiet Medtech Giant Matters to You - AD HOC NEWS
Segall Bryant & Hamill LLC Has $23.51 Million Position in Boston Scientific Corporation $BSX - MarketBeat
The Zacks Analyst Blog Highlights Apple, TotalEnergies, Boston Scientific and Good Times Restaurants - Bitget
Boston Scientific Corp.: Why This Quiet Medtech Giant Is Suddenly On Watch - AD HOC NEWS
FDA recalls Boston Scientific stents, following three deaths, 160+ serious injuries - Worcester Business Journal
Boston Scientific Corporation (BSX) Stock Analysis: With a 36.3% Potential Upside, Is It Time to Invest? - DirectorsTalk Interviews
Andra AP fonden Buys 18,900 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX): Buy, Sell, or Hold Post Q4 Earnings? - Finviz
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX) - marketscreener.com
Austin InnoA huge medtech acquisition | Mental health startup launches subscription - The Business Journals
Vaginal Mesh Lawsuit Settlements | March 2026 Update - Lawsuit Information Center
TIAA Trust National Association Has $19.28 Million Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Holdings Raised by Egerton Capital UK LLP - MarketBeat
American Century Companies Inc. Has $390.43 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Boston Scientific (NYSE: BSX) EVP logs 6,851-share 401(k) rebalancing move - Stock Titan
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Handelsbanken Fonder AB Sells 124,031 Shares of Boston Scientific Corporation $BSX - MarketBeat
R Squared Ltd Has $3.03 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Argus Adjusts Price Target on Boston Scientific to $115 From $130, Maintains Buy Rating - marketscreener.com
Boston Scientific Corporation $BSX Holdings Lowered by Artisan Partners Limited Partnership - MarketBeat
What Does the Street Think About Boston Scientific Corporation (BSX)? - Finviz
Boston Scientific Corp enters $3 billion revolving credit agreementSEC filing - marketscreener.com
Boston Scientific Wins Toss Of Spinal Device Suit - Law360
Boston Scientific Corporation Enter into A $3.000 Billion Revolving Credit Agreement - marketscreener.com
Boston Scientific (NYSE: BSX) lines up $11B to fund Penumbra deal - Stock Titan
Argus Lowers Boston Scientific Price Target to $115 From $130 - marketscreener.com
April 10th Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific Corporation (BSX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Mitsubishi UFJ Asset Management Co. Ltd. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Intech Investment Management LLC - MarketBeat
Sumitomo Life Insurance Co. Purchases 22,663 Shares of Boston Scientific Corporation $BSX - MarketBeat
TD Asset Management Inc Has $194.72 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Stock Underperforming the Dow? - Barchart.com
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Q4 Earnings Highlights: Boston Scientific (NYSE:BSX) Vs The Rest Of The Medical Devices & SuppliesDiversified Stocks - Yahoo Finance
[Form 3] BOSTON SCIENTIFIC CORP Initial Statement of Beneficial Ownership - Stock Titan
Boston Scientific (BSX) director reports 141 shares held indirectly by trust - Stock Titan
Boston Scientific Adds Starbucks And Takeda Leaders To Guide Capital And Growth - Yahoo Finance
Boston Scientific adds Starbucks CFO, Takeda CEO to board amid $14.5B buying spree - The Business Journals
Boston Scientific adds Starbucks CFO and biopharma giant CEO to board - Worcester Business Journal
Boston Scientific Corp. Experiences Valuation Adjustment Amidst Shifting Financial Landscape - Markets Mojo
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):